T

Todd C. Lee

McGill University Health Centre

ORCID: 0000-0002-2267-4239

Publishes on COVID-19 Clinical Research Studies, Antimicrobial Resistance in Staphylococcus, Bacterial Identification and Susceptibility Testing. 326 papers and 8.6k citations.

PubIndex Score63Top 37% · seniorHow it's scored

326Publications

8.6kTotal Citations

First publication: 2007First senior author: 2011

COVID-19 Clinical Research Studies Antimicrobial Resistance in Staphylococcus Bacterial Identification and Susceptibility Testing Long-Term Effects of COVID-19 Pharmaceutical Practices and Patient Outcomes

Top publicationsby citations

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

David R. Boulware, Kathy Huppler Hullsiek, Matthew F Pullen et al.|New England Journal of Medicine|2020

Cited by 1.4k

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19

Caleb P Skipper, David R. Boulware, Katelyn A Pastick et al.|Annals of Internal Medicine|2020

Cited by 548

Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2

Guillaume Butler‐Laporte, Todd C. Lee, Nandini Dendukuri et al.|JAMA Internal Medicine|2021

Cited by 327

Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis

Anthony D. Bai, Todd C. Lee, Carson K. L. Lo et al.|Clinical Microbiology and Infection|2022

Cited by 287

Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)

Katelyn A Pastick, David R. Boulware, Elizabeth C Okafor et al.|Open Forum Infectious Diseases|2020

Cited by 215